LENZ Therapeutics (LENZ) has announced that it will be unveiling its third quarter financial results on Wednesday 6th November 2024. This eagerly anticipated announcement is scheduled to occur before market open, ensuring that investors and analysts have the opportunity to gain valuable insights into the company's performance during the quarter.
the organization is poised to announce an estimated $0.46 loss per share for the quarter, as predicted by financial experts on Wall Street.
The forecasts for the company's annual performance have been disclosed by Wall Street analysts, with an estimated loss of $3.15 per share for the fiscal year.
The company's earnings report for the corresponding quarter of the previous year showcased a per-share loss of $2.73.
[stock_market_widget type=”chart” template=”line2″ assets=LENZ range=”1y” interval=”1wk” price_field=”close” heading=”{symbol}” line_width=”2″ gradient_direction=”bottom” gradient_size=”1″ line_color=”#1b6dc1″ area_background_color=”#1b6dc1″ area_background_color2=”#ffffff” axes_color=”#000000″ tooltip_text_color=”#262626″ tooltip_background_color=”#ffffff” range_selector=”false” volume_enabled=”false” axes_enabled=”true” tooltip_enabled=”false” events_enabled=”false” smoothing_enabled=”true” zoom_enabled=”false” save_image_enabled=”false” api=”yahoo-finance”]
Additionally, The company will host a conference call with investors and analysts on 6th November 2024 at 08:00 AM eastern time to review the Q3 2024 financial results.
LENZ Therapeutics (LENZ) experienced a trading range of $26.12 to $28.58, along with a total volume of 114.80 thousand shares during the day. The stock concluded Friday's regular trading session at $27.93, indicating a rise of 3.60 percent.
